African Cancer Genome: GMD

RecruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Breast CancerProstate Cancer
Interventions
OTHER

Standard of Care

Drugs routinely administered for breast cancer per local standard.

OTHER

Standard of Care

Drugs routinely administered for prostate cancer per local standard.

Trial Locations (1)

19111

RECRUITING

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

University of Miami Sylvester Comprehensive Cancer Center

OTHER

collaborator

Pfizer

INDUSTRY

collaborator

The University of The West Indies, Mona, Jamaica

UNKNOWN

collaborator

Kenya Medical Research Institute

OTHER

collaborator

University of Nairobi, Kenya

UNKNOWN

collaborator

University of Abomey Calavi, Benin

UNKNOWN

collaborator

Innovating Health International, Haiti

UNKNOWN

collaborator

Institut de Recherche en Sciences de la Sante, Burkina Faso

OTHER_GOV

collaborator

The University of the West Indies at Cave Hill, Barbados

UNKNOWN

collaborator

The University of The West Indies School of Clinical Medicine and Research, The Bahamas

UNKNOWN

collaborator

Ministry of Health and Social Services, Namibia

OTHER_GOV

collaborator

Morgan State University

OTHER

collaborator

University of Alabama, Tuscaloosa

OTHER

lead

Fox Chase Cancer Center

OTHER